Duke researcher Louise Markert receives FDA approval for groundbreaking treatment of pediatric immune disorder
By Velda Wang | November 1, 2021The groundbreaking therapy is the only available treatment for pediatric congenital athymia patients.
The independent news organization of Duke University
The groundbreaking therapy is the only available treatment for pediatric congenital athymia patients.
“She just rolls with the punches, so she’s ready to get back to some normalcy. She loves school and she loves riding the bus; she is ready to get back on the school bus.”
Three food trucks come to Duke on a rotating basis and can be found in the Swift parking lot from 5 to 7 p.m. Students can use their food points at the food trucks.
Senior Gracie Johnson etched her name into the Duke volleyball record books this season, hitting 1,000 career kills in October.